Survival disparities by Medicaid status

Cancer

Volumn 118, Issue 17, 2012, Pages 4271-4279

  Koroukian, Siran M ^a,b   Bakaki, Paul M ^a   Raghavan, Derek ^c,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d LEVINE CANCER INSTITUTE   (United States)

Author keywords

curable cancers; linked databases; Medicaid status; survival outcomes

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; COLON CANCER; EARLY CANCER; FEMALE; HEALTH DISPARITY; HODGKIN DISEASE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAID; MELANOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOCIAL STATUS; SURVIVAL TIME; TESTIS CANCER;

ADOLESCENT; ADULT; DATABASES AS TOPIC; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MEDICAID; MIDDLE AGED; NEOPLASMS; OHIO; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84865313587     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27380     Document Type: Article

References (28)

1. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004; 101: 3-27.
2. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005; 97: 1407-1427.
3. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.
4. Hayat MJ, Howlader N, Reichman ME, Edwards BK,. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007; 12: 20-37.
5. President's Cancer Panel 2009-2010 Annual Report: America's Demographic and Cultural Transformation - Implications for Cancer. Bethesda, MD: National Cancer Institute; 2011.
6. Goss E, Lopez AM, Brown CL, Wollins DS, Brawley OW, Raghavan D,. American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol. 2009; 27: 2881-2885.
7. Raghavan D,. Disparities in cancer care: challenges and solutions. Oncology (Williston Park). 2007; 21: 493-496; discussion 499, 503, 506.
8. Garner MJ, Turner MC, Ghadirian P, Krewski D,. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005; 116: 331-339.
9. Mirabello L, Troisi RJ, Savage SA,. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results program. Cancer. 2009; 115: 1531-1543.
10. Izawa JI, Al-Omar M, Winquist E, et al. Prognostic variables in adult Wilms tumour. Can J Surg. 2008; 51: 252-256.
11. Jawad MU, Haleem AA, Scully SP,. Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology. Cancer. 2011; 117: 1529-1541.
12. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003; 98: 571-580.
13. Rieken S, Mohr A, Habermehl D, et al. Outcome and prognostic factors of radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2011; 81: e7-e13.
14. Riffaud L, Saikali S, Leray E, et al. Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg. 2009; 111: 478-487.
15. Lai R,. Survival of patients with adult medulloblastoma: a population-based study. Cancer. 2008; 112: 1568-1574.
16. Narayanan S, Shami PJ,. Treatment of acute lymphoblastic leukemia in adults. Crit Rev Oncol Hematol. [published online ahead of print February 24, 2011.]
17. Bradley CJ, Given CW, Roberts C,. Late stage cancers in a Medicaid-insured population. Med Care. 2003; 41: 722-728.
18. O'Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI,. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health. 2006; 96: 2179-2185.
19. Perkins CI, Wright WE, Allen M, Samuels SJ, Romano PS,. Breast cancer stage at diagnosis in relation to duration of Medicaid enrollment. Med Care. 2001; 39: 1224-1233.
20. Koroukian SM,. Assessing the effectiveness of Medicaid in breast and cervical cancer prevention. J Public Health Manag Pract. 2003; 9: 306-314.
21. Ohio Cancer Incidence Surveillance System. Cancer Incidence Among Ohio Residents, 2000. Columbus, OH: Ohio Department of Health; 2004.
22. Koroukian SM, Cooper GS, Rimm AA,. Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population. Health Serv Res. 2003; 38: 947-960.
23. Koroukian SM,. Linking the Ohio Cancer Incidence Surveillance System with Medicare, Medicaid, and clinical data from home health care and long term care assessment instruments: paving the way for new research endeavors in geriatric oncology. J Registry Manag. 2008; 35: 156-165.
24. Koroukian SM, Bakaki PM, Beaird H, Earle CC, Cooper GS,. Cancer stage comparison between dual Medicare-Medicaid eligibles using Medicaid as a supplemental health insurance program and low-income duals. J Public Health Manag Pract. 2011; 17: 479-491.
25. Koroukian SM,. Screening mammography was used more, and more frequently, by longer than shorter term Medicaid enrollees. J Clin Epidemiol. 2004; 57: 824-831.
26. Krieger N,. Socioeconomic data in cancer registries. Am J Public Health. 2001; 91: 156-157.
27. Krieger N, Quesenberry C Jr, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control. 1999; 10: 525-537.
28. Krieger N,. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992; 82: 703-710.